Clinical Studies of Safety and Effectiveness of Orphan Products

The summary for the Clinical Studies of Safety and Effectiveness of Orphan Products grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Clinical Studies of Safety and Effectiveness of Orphan Products: The Food and Drug Administration (FDA) is announcing changes to its Office of Orphan Products Development (OPD) grant program for fiscal year (FY) 2006. This announcement supercedes the previous announcement of this program, which was published in the Federal Register of August 8, 2003 (68 FR 47340). Please note that there are new submission requests and requirements for this grant program. These include, but are not limited to, a requested letter of intent, a change in funding levels, a change in number of receipt dates, and changes in review criteria. Please note when accessing the URL below to select "Federal Register, Volume 70 (2005)" search for "page 2642" and click submit.
Federal Grant Title: Clinical Studies of Safety and Effectiveness of Orphan Products
Federal Agency Name: Food and Drug Administration
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-FDA-OPD-2006
Type of Funding: Grant
CFDA Numbers: 93.103
CFDA Descriptions: Food and Drug Administration_Research
Current Application Deadline: No deadline provided
Original Application Deadline: Apr 19, 2005 Applications will be accepted from 8
Posted Date: Feb 04, 2005
Creation Date: Feb 04, 2005
Archive Date: No date given
Total Program Funding: $13,200,000
Maximum Federal Grant Award: $350,000
Minimum Federal Grant Award:
Expected Number of Awards: 10
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
The grants are available to any foreign or domestic, public or private, for-profit or nonprofit entity (including State and local units of government). Federal agencies that are not part of the Department of Health and Human Services (HHS) may apply. Agencies that are part of HHS may not apply. For-profit entities must commit to excluding fees or profit in their request for support to receive grant awards. Organizations that engage in lobbying activities, as described in section 501(c)(4) of the Internal Revenue Code of 1968, are not eligible to receive grant awards. An application that has received two prior disapprovals is not eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
Polit, Cynthia, Senior Grants Management Specialist, Phone 301-827-7182, Fax 301-827-7101, Email cpolit@oc.fda.gov cpolit@oc.fda.gov Polit, Cynthia
Similar Government Grants
Expanded Access to Investigational Therapies (R01)
FDA Scientific Conference Grant Program (R13)
Dissolution Methods for Semisolid Ocular Drug Products
Dissolution Methods for Microsphere and Implant Drug Products
Dissolution Methods for Suspension and Emulsion Ocular Drug Products
Support for Small Scientific Conference Grant Program
Cooperative Agreement to Support the World Health Organization (WHO) International Program...
FDA State Food Safety Task Force Conference
More Grants from the Food and Drug Administration
Expanded Access to Investigational Therapies (R01)
FDA Scientific Conference Grant Program (R13)
Dissolution Methods for Semisolid Ocular Drug Products

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2016 FederalGrants.com